IBDEI1OC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28445,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,28445,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,28445,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,28446,0)
 ;;=E11.641^^112^1421^16
 ;;^UTILITY(U,$J,358.3,28446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28446,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,28446,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,28446,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,28447,0)
 ;;=E11.649^^112^1421^17
 ;;^UTILITY(U,$J,358.3,28447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28447,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,28447,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,28447,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,28448,0)
 ;;=H40.11X0^^112^1422^9
 ;;^UTILITY(U,$J,358.3,28448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28448,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Unspec Stage
 ;;^UTILITY(U,$J,358.3,28448,1,4,0)
 ;;=4^H40.11X0
 ;;^UTILITY(U,$J,358.3,28448,2)
 ;;=^5005753
 ;;^UTILITY(U,$J,358.3,28449,0)
 ;;=H40.11X1^^112^1422^6
 ;;^UTILITY(U,$J,358.3,28449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28449,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Mild Stage
 ;;^UTILITY(U,$J,358.3,28449,1,4,0)
 ;;=4^H40.11X1
 ;;^UTILITY(U,$J,358.3,28449,2)
 ;;=^5005754
 ;;^UTILITY(U,$J,358.3,28450,0)
 ;;=H40.11X2^^112^1422^7
 ;;^UTILITY(U,$J,358.3,28450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28450,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Moderate Stage
 ;;^UTILITY(U,$J,358.3,28450,1,4,0)
 ;;=4^H40.11X2
 ;;^UTILITY(U,$J,358.3,28450,2)
 ;;=^5005755
 ;;^UTILITY(U,$J,358.3,28451,0)
 ;;=H40.11X3^^112^1422^8
 ;;^UTILITY(U,$J,358.3,28451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28451,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Severe Stage
 ;;^UTILITY(U,$J,358.3,28451,1,4,0)
 ;;=4^H40.11X3
 ;;^UTILITY(U,$J,358.3,28451,2)
 ;;=^5005756
 ;;^UTILITY(U,$J,358.3,28452,0)
 ;;=H40.11X4^^112^1422^5
 ;;^UTILITY(U,$J,358.3,28452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28452,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,28452,1,4,0)
 ;;=4^H40.11X4
 ;;^UTILITY(U,$J,358.3,28452,2)
 ;;=^5005757
 ;;^UTILITY(U,$J,358.3,28453,0)
 ;;=H11.33^^112^1422^2
 ;;^UTILITY(U,$J,358.3,28453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28453,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Bilateral
 ;;^UTILITY(U,$J,358.3,28453,1,4,0)
 ;;=4^H11.33
 ;;^UTILITY(U,$J,358.3,28453,2)
 ;;=^5004784
 ;;^UTILITY(U,$J,358.3,28454,0)
 ;;=H11.31^^112^1422^4
 ;;^UTILITY(U,$J,358.3,28454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28454,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,28454,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,28454,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,28455,0)
 ;;=H11.32^^112^1422^3
 ;;^UTILITY(U,$J,358.3,28455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28455,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,28455,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,28455,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,28456,0)
 ;;=H61.23^^112^1422^13
 ;;^UTILITY(U,$J,358.3,28456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28456,1,3,0)
 ;;=3^Impacted Cerumen,Bilateral
 ;;^UTILITY(U,$J,358.3,28456,1,4,0)
 ;;=4^H61.23
 ;;^UTILITY(U,$J,358.3,28456,2)
 ;;=^5006533
 ;;^UTILITY(U,$J,358.3,28457,0)
 ;;=H61.22^^112^1422^14
 ;;^UTILITY(U,$J,358.3,28457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28457,1,3,0)
 ;;=3^Impacted Cerumen,Left Ear
 ;;^UTILITY(U,$J,358.3,28457,1,4,0)
 ;;=4^H61.22
 ;;^UTILITY(U,$J,358.3,28457,2)
 ;;=^5006532
 ;;^UTILITY(U,$J,358.3,28458,0)
 ;;=H66.91^^112^1422^18
